Explore the latest in sexual dysfunctions, including erectile dysfunction, hypoactive sexual desire, orgasmic disorders, and more.
This randomized clinical trial assesses the safety and efficacy of carbon dioxide (CO2) vs sham vaginal laser treatment after 6 months of follow-up in survivors of breast cancer receiving aromatase inhibitors with genitourinary syndrome of menopause.
This randomized clinical trial investigates the physiological, behavioral, neural, and hormonal effects of kisspeptin administration in men with hypoactive sexual desire disorder.
This survey study explores the knowledge, attitudes, and practice patterns related to sexual dysfunction among urologists and andrologists in China.
This randomized clinical trial of 32 premenopausal women with hypoactive sexual desire disorder examines the effectiveness of a kisspeptin infusion in enhancing sexual and attraction brain processing.
This JAMA Insights in the Women’s Health series describes the identification and management of dyspareunia to help address sexual pain; successful treatment can have benefits for both physical and mental health.
This randomized clinical trial evaluates the immediate efficacy of testosterone-suppressing medication in reducing the risk scores in 5 domains of child sexual abuse among men with pedophilic disorder.
This survey study of adults aged 18 to 44 years examines trends in reported frequency of sexual activity and number of sexual partners and the association between measures of sexual activity and sociodemographic variables.
This survey study investigates the prevalence of distress and impairment associated with difficulty controlling one’s sexual feelings, urges, and behaviors among US men and women.
This cohort study evaluates the association of sexual quality of life in patients with newly diagnosed obstructive sleep apnea who used continuous positive airway pressure (CPAP) for 12 months vs those who did not use CPAP.
This Medical Letter review summarizes treatment options for dyspareunia, focusing on use of intravaginal prasterone for treatment of moderate to severe dyspareunia in postmenopausal women.
This Teachable Moment calls attention to the need to investigate the underlying cause of low testosterone levels or symptoms of hypogonadism.
This secondary analysis of clinical trial data examines older men assigned to intermittent androgen-deprivation therapy to determine frequency of bone, endocrine, cognitive, ischemic, and thrombotic events.
This systematic review and meta-analysis of randomized clinical trials assesses the efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women.
Customize your JAMA Network experience by selecting one or more topics from the list below.